Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

MaxCyte (MXCT)

MaxCyte Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:MXCT
DateTimeSourceHeadlineSymbolCompany
10/12/202421:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MXCTMaxCyte Inc
09/12/202413:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MXCTMaxCyte Inc
09/12/202407:00GlobeNewswire Inc.MaxCyte Announces Streamlined Operations and Raises 2024 Revenue GuidanceNASDAQ:MXCTMaxCyte Inc
14/11/202400:14Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:MXCTMaxCyte Inc
13/11/202413:05GlobeNewswire Inc.MaxCyte Celebrates 25 Years of Innovation Driving Cell Engineering-Based TherapeuticsNASDAQ:MXCTMaxCyte Inc
08/11/202422:31Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:MXCTMaxCyte Inc
06/11/202421:55Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MXCTMaxCyte Inc
06/11/202421:22Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MXCTMaxCyte Inc
06/11/202421:05GlobeNewswire Inc.MaxCyte Reports Third Quarter 2024 Financial Results and Updates Full Year 2024 GuidanceNASDAQ:MXCTMaxCyte Inc
05/11/202421:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MXCTMaxCyte Inc
31/10/202420:23Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:MXCTMaxCyte Inc
31/10/202412:05GlobeNewswire Inc.MaxCyte to Participate in Two Upcoming Investor ConferencesNASDAQ:MXCTMaxCyte Inc
30/10/202420:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MXCTMaxCyte Inc
21/10/202420:11Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:MXCTMaxCyte Inc
16/10/202421:36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MXCTMaxCyte Inc
16/10/202421:32Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MXCTMaxCyte Inc
15/10/202420:40Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MXCTMaxCyte Inc
15/10/202412:05GlobeNewswire Inc.MaxCyte Appoints Cynthia Collins to its Board of DirectorsNASDAQ:MXCTMaxCyte Inc
11/10/202412:05GlobeNewswire Inc.MaxCyte to Report Third Quarter 2024 Financial Results on November 6, 2024NASDAQ:MXCTMaxCyte Inc
10/10/202412:05GlobeNewswire Inc.MaxCyte Appoints Ali Soleymannezhad as Chief Commercial OfficerNASDAQ:MXCTMaxCyte Inc
02/10/202421:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MXCTMaxCyte Inc
30/09/202420:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MXCTMaxCyte Inc
26/09/202420:11Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MXCTMaxCyte Inc
18/09/202420:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MXCTMaxCyte Inc
18/09/202420:28Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MXCTMaxCyte Inc
16/09/202406:00GlobeNewswire Inc.MaxCyte Signs Strategic Platform License with Kamau Therapeutics to Accelerate the Development of Cell Therapies for Genetic DiseasesNASDAQ:MXCTMaxCyte Inc
05/09/202420:05GlobeNewswire Inc.MaxCyte to Participate in Virtual Craig-Hallum Capital Group Bioprocessing ConferenceNASDAQ:MXCTMaxCyte Inc
03/09/202420:36Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:MXCTMaxCyte Inc
28/08/202420:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MXCTMaxCyte Inc
06/08/202420:55Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MXCTMaxCyte Inc
 Showing the most relevant articles for your search:NASDAQ:MXCT